Johnson & Johnson (JNJ) Stock Near Record Highs: Is the $500 Billion Healthcare Giant Still a Buy in 2025?
Johnson & Johnson stock surged to an all-time high close of $207.56 on November 26, 2025, lifting its market value above $500 billion for the first time. Shares are up about 45% year-to-date, far outpacing the S&P 500. The rally follows strong Q3 results, raised guidance, and momentum from new drugs, despite ongoing litigation and product setbacks. JNJ now trades at 19.8 times trailing earnings.